Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $220.68 | 11 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Neurocrine Biosciences, Inc. | $39.69 | 2 | $0 (2024) |
| ABBVIE INC. | $38.22 | 2 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $29.82 | 1 | $0 (2024) |
| Indivior Inc. | $24.91 | 1 | $0 (2024) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $22.44 | 1 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $19.67 | 1 | $0 (2024) |
| Vanda Pharmaceuticals Inc. | $15.87 | 1 | $0 (2024) |
| IDORSIA PHARMACEUTICALS US INC | $15.23 | 1 | $0 (2024) |
| Noven Therapeutics, LLC | $14.83 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $220.68 | 11 | Neurocrine Biosciences, Inc. ($39.69) |
All Payment Transactions
11 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.97 | General |
| Category: NEUROSCIENCE | ||||||
| 09/17/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $22.44 | General |
| Category: PSYCHIATRY | ||||||
| 08/06/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $15.87 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 07/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.25 | General |
| Category: NEUROSCIENCE | ||||||
| 07/16/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: Insomnia | ||||||
| 05/07/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), REXULTI | Food and Beverage | In-kind items and services | $29.82 | General |
| Category: PSYCHIATRY | ||||||
| 04/16/2024 | Indivior Inc. | PERSERIS (Drug) | Food and Beverage | In-kind items and services | $24.91 | General |
| Category: BH | ||||||
| 04/02/2024 | Noven Therapeutics, LLC | Xelstrym (Drug) | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: ADHD | ||||||
| 03/26/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $19.67 | General |
| Category: NEUROSCIENCE | ||||||
| 03/19/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $20.40 | General |
| Category: Neuropsychiatry | ||||||
| 01/23/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $19.29 | General |
| Category: Neuropsychiatry | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 155 | 265 | $39,800 | $19,604 |
All Medicare Procedures & Services
5 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 61 | 167 | $19,205 | $9,989 | 52.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 47 | 47 | $10,575 | $4,388 | 41.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 16 | 16 | $4,000 | $2,124 | 53.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 20 | 22 | $4,070 | $1,918 | 47.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 11 | 13 | $1,950 | $1,184 | 60.7% |
About Dr. Jon Guidry, MD
Dr. Jon Guidry, MD is a Psychiatry healthcare provider based in Tyler, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1942384276.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jon Guidry, MD has received a total of $220.68 in payments from pharmaceutical and medical device companies, with $220.68 received in 2024. These payments were reported across 11 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($220.68).
As a Medicare-enrolled provider, Guidry has provided services to 155 Medicare beneficiaries, totaling 265 services with total Medicare billing of $19,604. Data is available for 1 year (2023–2023), covering 5 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Location Tyler, TX
- Active Since 10/24/2006
- Last Updated 02/01/2013
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1942384276
Products in Payments
- INGREZZA (Drug) $39.69
- VRAYLAR (Drug) $38.22
- ABILIFY MAINTENA (Drug) $29.82
- PERSERIS (Drug) $24.91
- CAPLYTA (Drug) $22.44
- TRINTELLIX (Drug) $19.67
- HETLIOZ (Drug) $15.87
- QUVIVIQ (Drug) $15.23
- Xelstrym (Drug) $14.83
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Tyler
Gary Wilson, Md, MD
Psychiatry — Payments: $4,403
Chance Mcinnis
Psychiatry — Payments: $4,281
David Danly, Md, MD
Psychiatry — Payments: $4,150
Dr. Douglas Ghrist, M.d, M.D
Psychiatry — Payments: $1,644
Igal Tarash, Do Md Emba, DO MD EMBA
Psychiatry — Payments: $734.11
Phyllis Ramirez, Md, MD
Psychiatry — Payments: $712.87